Chris Lewis
Stock Analyst at Roth Capital
(3.03)
# 1,218
Out of 5,173 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $8.15 | -50.92% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $99.20 | -83.87% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $31.75 | -54.33% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $104.91 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.35 | +1,381.48% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $8.15
Upside: -50.92%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $99.20
Upside: -83.87%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $31.75
Upside: -54.33%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $104.91
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.35
Upside: +1,381.48%